M. Sue O’Dorisio

Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

J Costello, Michael C. Frühwald, Dominic J. Smiraglia et al. · Nature Genetics · 2000 · 1.4K citations

Cancer Research, Epigenetic Regulation, Medicine +11

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 790 citations · Full text

The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors

Herbert Chen, Rebecca S. Sippel, M. Sue O’Dorisio et al. · Pancreas · 2010 · 580 citations · Full text

Endocrine Oncology, Surgical Oncology, Endocrine Disease +13

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors

Thomas A. Hope, Emily K. Bergsland, Murat Fani Bozkurt et al. · Journal of Nuclear Medicine · 2017 · 331 citations · Full text

Sstr Pet, Oncologic Imaging, Conventional Imaging +17

⁹⁰Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

David Bushnell, Thomas M. O’Dorisio, M. Sue O’Dorisio et al. · Journal of Clinical Oncology · 2010 · 303 citations · Full text